Autres langues The Calmer Co International Limited

Actions

CCO

AU0000275216

Produits pharmaceutiques

Marché Fermé - Australian S.E. Autres places de cotation 08:10:26 21/07/2026			Varia. 5j.	Varia. 1 janv.
0,002000 ^AUD	0,00 %		0,00 %	-50,00 %

24/06	Coles Group accepte le référencement du nouveau produit à base de kava de Calmer Co International	MT
08/05	Transcript : The Calmer Co International Limited, Q3 2026 Earnings Call, May 07, 2026

Autres langues

24/06	Coles Group Accepts Ranging of Calmer Co International's New Kava Product
30/04	Calmer Co International posts quarterly revenue of A$1.96 million
08/04	The Calmer Co International Limited Appoints Karl Schlobohm as Non-Executive Director, Effective April 8, 2026
26/02	The Calmer Co International Limited Reports Earnings Results for the Half Year Ended December 31, 2025
26/02	Calmer Co International announces A$1.6 million placement at issue price of A$0.0035 per share
26/02	Calmer Co International secures A$2m annual minimum revenue via supply agreement
24/02	Calmer Co International seeks trading halt
12/02	The Calmer Co International Limited Announces Registered Office & Principal Place of Business Address Change, Effective from 22 February 2026
01/02	The Calmer Co International Limited Announces Resignation of Dr. Anthony Noble as A Non-Executive Director, Effective 1 February 2026
23/12	Calmer Co International says FDA confirms kava as a food under federal law
18/12	The Calmer Co International Limited announced that it has received AUD 1.4 million in funding from Applied Food Sciences, Inc.
06/11	Calmer Co International says John Homewood steps down as chairman
28/10/25	Calmer Co International posts quarterly revenue of A$2.4 million
03/10/25	Calmer Co International says in Q1 delivered record sales of A$2.4 million
03/10/25	Calmer Achieves Record AU$2.4 Million Quarterly Revenue
03/10/25	The Calmer Co International Limited Reports Revenue Results for the First Quarter of Fiscal Year 2026
29/09/25	The Calmer Co International Limited announced that it expects to receive AUD 1.4 million in funding
29/09/25	Calmer Co International secures A$1.4m via convertible note raise
04/09/25	The Calmer Co International Says August Sales Up 17% from July
29/08/25	The Calmer Co International Limited Reports Earnings Results for the Full Year Ended June 30, 2025
28/08/25	The Calmer Co International Limited Auditor Raises 'Going Concern' Doubt
08/08/25	The Calmer Co International Secures Three Year Term Under Fiji Manufacturing Facility Lease Agreement
06/08/25	Calmer International Says Coles Retail Sales Increases In July
31/07/25	Calmer Co International posts Q4 revenue A$1.9 mln, up 6% versus Q3
23/06/25	The Calmer Launches Kava Tinctures on Amazon USA